Wednesday, November 1, 2006

Pathway Medical Raises $25M

Redmond, Washington-based Pathway Medical Technologies said today that it has raised $25M in a Series B funding. HLM Venture Partners, a new investor in the firm, led the round. The firm also added Latterell Venture Partners as a new investor. Existing investors ABN AMRO Capital Lifesciences, Giza Ventures and Oxford Bioscience also participated. Pathway is developing endovascular treatments for peripheral arterial disease. More information »